Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Sunny Enterprises Inc., 4022-4023 [2023-01207]
Download as PDF
<![CDATA[
4022
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
following basic class(es) of controlled
substance(s):
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances
Application: Medi-Physics Inc. dba GE
Healthcare
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Medi-Physics Inc. dba GE
Healthcare has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before February 22, 2023. Such
persons may also file a written request
for a hearing on the application on or
before February 22, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on December 14, 2022,
Medi-Physics Inc. dba GE Healthcare,
3350 North Ridge Avenue, Arlington
Heights, Illinois 60004–1412, applied to
be registered as an importer of the
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:44 Jan 20, 2023
Drug
code
Controlled substance
[Docket No. DEA–1135]
Jkt 259001
Cocaine ........................
Ecgonine .......................
I
9041
9180
Schedule
II
III
The company plans to import
derivatives of the listed controlled
substances to be used for the
manufacture of a diagnostic product and
reference standards. No other activity
for these drug codes is authorized for
this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–01206 Filed 1–20–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1136]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Sunny
Enterprises Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
DATES:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.’’
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
submit electronic comments on or
objections of the requested registration,
as provided in this notice. This notice
does not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(API) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on December 6, 2022, Sunny Enterprises
Inc, 4562 Meridian Street, Bellingham,
Washington 98226, applied to be
registered as a bulk manufacturer of the
E:\FR\FM\23JAN1.SGM
23JAN1
Federal Register / Vol. 88, No. 14 / Monday, January 23, 2023 / Notices
following basic class(es) of controlled
substances:
Controlled substance
Marihuana .....................
Drug
code
7360
Schedule
[FR Doc. 2023–01207 Filed 1–20–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1128]
Bulk Manufacturer of Controlled
Substances Application: Organic
Consultants LLC DBA Cascade
Chemistry
Drug
code
Controlled substance
I
Matthew Strait,
Deputy Assistant Administrator.
khammond on DSKJM1Z7X2PROD with NOTICES
200, Eugene, Oregon 97402–4109,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Amphetamine .........................
Methylphenidate .....................
Codeine ..................................
Oxycodone .............................
Hydromorphone .....................
Hydrocodone ..........................
Meperidine .............................
Meperidine intermediate-A .....
Meperidine intermediate-B .....
Meperidine intermediate-C ....
Methadone .............................
Methadone intermediate ........
Morphine ................................
Thebaine ................................
Oxymorphone ........................
Noroxymorphone ...................
Fentanyl .................................
Schedule
1100
1724
9050
9143
9150
9193
9230
9232
9233
9234
9250
9254
9300
9333
9652
9668
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture small quantities of the
AGENCY: Drug Enforcement
listed controlled substances for internal
Administration, Justice.
use or for sale as analytical reference
ACTION: Notice of application.
standard materials to its customers. No
SUMMARY: Organic Consultants LLC DBA other activities for these drug codes are
authorized for this registration.
Cascade Chemistry has applied to be
registered as a bulk manufacturer of
Matthew Strait,
basic class(es) of controlled
Deputy Assistant Administrator.
substance(s). Refer to SUPPLEMENTARY
[FR Doc. 2023–01133 Filed 1–20–23; 8:45 am]
INFORMATION listed below for further
BILLING CODE P
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
DEPARTMENT OF LABOR
applicants therefore, may submit
electronic comments on or objections to Employee Benefits Security
the issuance of the proposed registration Administration
on or before March 24, 2023. Such
persons may also file a written request
[Prohibited Transaction Exemption 2023–
02; Exemption Application No. D–12067]
for a hearing on the application on or
before March 24, 2023.
Exemption for Certain Prohibited
ADDRESSES: The Drug Enforcement
Transaction Restrictions Involving
Administration requires that all
Citigroup, Inc. (Citigroup or the
comments be submitted electronically
through the Federal eRulemaking Portal, Applicant), Located in New York, New
York
which provides the ability to type short
comments directly into the comment
AGENCY: Employee Benefits Security
field on the web page or attach a file for Administration, Labor.
lengthier comments. Please go to
ACTION: Notice of exemption.
https://www.regulations.gov and follow
the online instructions at that site for
SUMMARY: This document contains a
submitting comments. Upon submission notice of an exemption issued by the
of your comment, you will receive a
Department of Labor (the Department)
Comment Tracking Number. Please be
extending the exemptive relief provided
aware that submitted comments are not
by PTE 2017–05 for an additional four
instantaneously available for public
(4) years. This exemption provides that
view on https://www.regulations.gov. If
certain entities with specified
you have received a Comment Tracking
relationships to Citigroup (hereinafter,
Number, your comment has been
the Citigroup Affiliated QPAMs and the
successfully submitted and there is no
Citigroup Related QPAMs, as defined in
need to resubmit the same comment.
Sections I(b) and I(c), respectively) will
not be precluded from relying on the
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this exemptive relief provided by Prohibited
Transaction Class Exemption 84–14
is notice that on November 9, 2022,
(PTE 84–14 or the QPAM Exemption),
Organic Consultants LLC DBA Cascade
notwithstanding the Conviction
Chemistry, 90 North Polk Street, Suite
VerDate Sep<11>2014
16:44 Jan 20, 2023
Jkt 259001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
4023
(defined in Section I(a)), during the
Exemption Period (as defined in Section
I(d)).
DATES: This exemption will be in effect
from January 10, 2023, through January
9, 2027.
FOR FURTHER INFORMATION CONTACT:
Anna Mpras Vaughan of the Department
at (202) 693–8565. (This is not a toll-free
number.)
SUPPLEMENTARY INFORMATION: The
Applicant requested an individual
exemption pursuant to ERISA Section
408(a) in accordance with the
procedures set forth in 29 CFR part
2570, subpart B (76 FR 66637, 66644,
October 27, 2011). On November 16,
2022, the Department published a notice
of proposed exemption (the Proposed
Exemption) in the Federal Register that
would permit Citigroup Affiliated
QPAMs and the Citigroup Related
QPAMs to continue relying on the
exemptive relief provided by the QPAM
Exemption notwithstanding the
Conviction provided certain conditions
are met.1
The Conviction: On January 10, 2017,
Citicorp, a Delaware corporation that is
a financial services holding company
and the direct parent company of
Citigroup, pled guilty to one count of an
antitrust violation of the Sherman
Antitrust Act (15 U.S.C. 1) arising from
an investigation conducted by the U.S.
Department of Justice (DOJ) of certain
conduct and practices of Citigroup and
other financial services firms in the
foreign exchange (FX) spot market.2 As
set forth in the Plea Agreement, from at
least December 2007 until at least
January 2013, Citicorp, through one
London-based Euro/U.S. dollar (EUR/
USD) trader employed by Citibank and
other traders at unrelated financial
services firms acting as dealers in the
FX spot market entered into and
engaged in a conspiracy to fix, stabilize,
maintain, increase or decrease the price
of, and rig bids and offers for, the EUR/
USD currency pair exchanged in the FX
spot market by agreeing to eliminate
competition in the purchase and sale of
the EUR/USD currency pair in the
United States and elsewhere (the
Criminal Misconduct). The Criminal
Misconduct included almost daily
conversations, some of which were in
code, in an exclusive electronic chat
room used by certain EUR/USD traders,
including the EUR/USD trader
employed by Citibank. The Criminal
1 87
FR 68728, November 16, 2022.
plea agreement with the DOJ (the Plea
Agreement), was approved by the U.S. District
Court for the District of Connecticut (the District
Court) on January 10, 2017 (Case Number 3:15–cr–
78–SRU).
2 Citicorp’s
E:\FR\FM\23JAN1.SGM
23JAN1
]]>Agencies
[Federal Register Volume 88, Number 14 (Monday, January 23, 2023)]
[Notices]
[Pages 4022-4023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01207]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 1136]
Bulk Manufacturer of Controlled Substances Application: Bulk
Manufacturer of Marihuana: Sunny Enterprises Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is providing notice
of an application it has received from an entity applying to be
registered to manufacture in bulk basic class(es) of controlled
substances listed in schedule I. DEA intends to evaluate this and other
pending applications according to its regulations governing the program
of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
March 24, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.''
SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA)
prohibits the cultivation and distribution of marihuana except by
persons who are registered under the CSA to do so for lawful purposes.
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is
providing notice that the entity identified below has applied for
registration as a bulk manufacturer of schedule I controlled
substances. In response, registered bulk manufacturers of the affected
basic class(es), and applicants therefor, may submit electronic
comments on or objections of the requested registration, as provided in
this notice. This notice does not constitute any evaluation or
determination of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical
ingredients (API) for product development and distribution to DEA
registered researchers. If the application for registration is granted,
the registrant would not be authorized to conduct other activity under
this registration aside from those coincident activities specifically
authorized by DEA regulations. DEA will evaluate the application for
registration as a bulk manufacturer for compliance with all applicable
laws, treaties, and regulations and to ensure adequate safeguards
against diversion are in place.
As this applicant has applied to become registered as a bulk
manufacturer of marihuana, the application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the
manner described in the rule published at 85 FR 82333 on December 18,
2020, and reflected in DEA regulations at 21 CFR part 1318.
In accordance with 21 CFR 1301.33(a), DEA is providing notice that
on December 6, 2022, Sunny Enterprises Inc, 4562 Meridian Street,
Bellingham, Washington 98226, applied to be registered as a bulk
manufacturer of the
[[Page 4023]]
following basic class(es) of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
------------------------------------------------------------------------
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-01207 Filed 1-20-23; 8:45 am]
BILLING CODE P
